HomeNewsTrendsHealthCOVID-19: NRI on Gujarat visit tests positive for Omicron sub-variant BA.5

COVID-19: NRI on Gujarat visit tests positive for Omicron sub-variant BA.5

The man, who lives in South Africa, had on May 1 tested positive for the coronavirus after he arrived to meet his parents.

May 24, 2022 / 16:36 IST
Representative image

A 29-year-old NRI who recently came to Vadodara in Gujarat from South Africa has been found infected with the BA.5 sub-variant of the highly-transmittable Omicron variant of coronavirus, a health official said on Tuesday.

The man, who lives in South Africa, had on May 1 tested positive for the coronavirus after he arrived here to meet his parents.

He had left for New Zealand on May 10 after testing negative for the virus, Vadodara Municipal Corporation’s chief health officer Dr Devesh Patel said.

His sample was sent to a laboratory in Gandhinagar for genome sequence.

The report, received on Tuesday, confirmed that he was infected with the BA.5 sub-variant of the Omicron variant of coronavirus, he said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"After testing positive for the coronavirus on May 1, the man was under self-isolation. He tested negative before leaving for New Zealand on May 10. His current whereabouts are not known,” Dr Patel said.

"The patient showed no symptoms. His parents, who were his only contacts, had tested negative for COVID-19 at that time. They have again tested negative for the virus,” the official said.

The Indian SARS-CoV-2 Genomics Consortium (INSACOG) had on Sunday confirmed the presence of the BA.4 and BA.5 Omicron sub-variants of the coronavirus in India- one case in Tamil Nadu and another in Telangana.

BA.4 and BA.5 are sub-variants of the highly-transmissible Omicron variant circulating globally.

These were first reported from South Africa earlier this year and are now being reported from several other countries.

The INSACOG had said these sub-variants have not been associated with disease severity or increased hospitalisation.

PTI
first published: May 24, 2022 04:36 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347